Machine Learning System for Lung Neoplasms Distinguished Based on Scleral Data

Author:

Huang Qin1,Lv Wenqi1,Zhou Zhanping2,Tan Shuting3,Lin Xue1,Bo Zihao2,Fu Rongxin1,Jin Xiangyu1,Guo Yuchen4,Wang Hongwu56,Xu Feng2,Huang Guoliang17

Affiliation:

1. Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing 100084, China

2. BNRist and School of Software, Tsinghua University, Beijing 100084, China

3. Graduate School, Adamson University, Manila 1000, Philippines

4. Beijing National Research Center for Information Science and Technology, Tsinghua University, Beijing 100084, China

5. Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China

6. Emergency General Hospital, Beijing 100000, China

7. National Engineering Research Center for Beijing Biochip Technology, Beijing 102206, China

Abstract

Lung cancer remains the most commonly diagnosed cancer and the leading cause of death from cancer. Recent research shows that the human eye can provide useful information about one’s health status, but few studies have revealed that the eye’s features are associated with the risk of cancer. The aims of this paper are to explore the association between scleral features and lung neoplasms and develop a non-invasive artificial intelligence (AI) method for detecting lung neoplasms based on scleral images. A novel instrument was specially developed to take the reflection-free scleral images. Then, various algorithms and different strategies were applied to find the most effective deep learning algorithm. Ultimately, the detection method based on scleral images and the multi-instance learning (MIL) model was developed to predict benign or malignant lung neoplasms. From March 2017 to January 2019, 3923 subjects were recruited for the experiment. Using the pathological diagnosis of bronchoscopy as the gold standard, 95 participants were enrolled to take scleral image screens, and 950 scleral images were fed to AI analysis. Our non-invasive AI method had an AUC of 0.897 ± 0.041(95% CI), a sensitivity of 0.836 ± 0.048 (95% CI), and a specificity of 0.828 ± 0.095 (95% CI) for distinguishing between benign and malignant lung nodules. This study suggested that scleral features such as blood vessels may be associated with lung cancer, and the non-invasive AI method based on scleral images can assist in lung neoplasm detection. This technique may hold promise for evaluating the risk of lung cancer in an asymptomatic population in areas with a shortage of medical resources and as a cost-effective adjunctive tool for LDCT screening at hospitals.

Funder

National Key Research and Development Program of China

Sichuan Science and Technology Program

National Natural Science Foundation of China

Vanke Special Fund for Public Health and Health Discipline Development, Tsinghua University

Tsinghua University Spring Breeze Fund

the Beijing Lab Foundation, and the Tsinghua Autonomous Research Foundation

Tsinghua Laboratory Innovation Fund

Publisher

MDPI AG

Subject

Clinical Biochemistry

Reference30 articles.

1. Global Cancer Statistics 2020: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

2. Cancer Statistics, 2022;Siegel;CA Cancer J. Clin.,2022

3. National Cancer Registration and Analysis Service, Public Health England (PHE) (2022, December 02). Cancer Survival in England for Patients Diagnosed between 2014 and 2018, and Followed up to 2019. C2022, Available online: https://www.gov.uk/government/statistics.

4. European Code against Cancer, 4th Edition: Tobacco and Cancer;Leon;Cancer Epidemiol.,2015

5. Oncology Committee of Chinese Medical Association, National Medical Journal of China (2022). Guidelines for the clinical diagnosis and treatment of lung cancer from the Chinese Medical Association (2022). Natl. Med. J. China, 102, 1706–1740.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3